Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (1371-1380 of 5,911) with videos related to

Pageof 592
Sort By:
The Prostate|December 15, 2024
PSA Density and Lesion Volume: Key Factors in Avoiding Unnecessary Biopsies for PI-RADS 3 LesionsAli Ayranci, Ufuk Caglar, Huseyin Burak Yazili, et al.
The Prostate|January 3, 2025
Exogenous Treatment of Caffeic Acid and Methylglyoxal Synergistically Enhances Anticancer Effect in Prostate Cancer via Inhibition of Glyoxalase-1Km Anjaly, Ashu Bhan Tiku
The Prostate|December 27, 2023
A prospective, randomized, open-label, parallel trial comparing the efficacy of α-blocker or 5α-reductase inhibitor withdrawal to continued combination therapy on the maintenance of lower urinary tract symptoms in men with benign prostatic hyperplasiaKwang Suk Lee, Jeong Woo Yoo, Dae Ho Kim, et al.
The Prostate|December 25, 2023
PrLZ regulates EMT and invasion in prostate cancer via the TGF-β1/p-smad2/miR-200 family/ZEB1 axisHongjun Xie, Jiaqi Chen, Zhenkun Ma, et al.
The Prostate|February 8, 2024
Estimating disparities of prostate cancer burden and its attributable risk factors for males across the BRICS-plus, 1990-2019: A comparable study of key nations with emerging economiesLi-Sha Luo, Jiao Huang, Hang-Hang Luan, et al.
The Prostate|February 5, 2024
Impact of presentation timing in metastatic hormone-sensitive prostate cancer: Characterization of patients and identification of prognostic factorsJuliana Arenas Hoyos, David Ruiz Londoño, Andres Gomez Hoyos, et al.
The Prostate|February 5, 2024
Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open-label, phase 2 trialAlbertas Ulys, Feliksas Jankevicus, Mindaugas Jievaltas, et al.
The Prostate|January 9, 2024
Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathwaysJason A White, Ernest T Kaninjing, Kayode A Adeniji, et al.
The Prostate|January 12, 2024
Metabolic analysis using HR-MAS in prostate tissue for prostate cancer diagnosisJorge Panach-Navarrete, Vannina González-Marrachelli, José Manuel Morales-Tatay, et al.
The Prostate|March 18, 2024
VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approachHendrik Heers, Oliver Chwilka, Johannes Huber, et al.
Pageof 592

Showing results (1371-1380 of 5,911) with videos related to

Sort By:
Pageof 592
The Prostate|December 15, 2024
PSA Density and Lesion Volume: Key Factors in Avoiding Unnecessary Biopsies for PI-RADS 3 LesionsAli Ayranci, Ufuk Caglar, Huseyin Burak Yazili, et al.
The Prostate|January 3, 2025
Exogenous Treatment of Caffeic Acid and Methylglyoxal Synergistically Enhances Anticancer Effect in Prostate Cancer via Inhibition of Glyoxalase-1Km Anjaly, Ashu Bhan Tiku
The Prostate|December 27, 2023
A prospective, randomized, open-label, parallel trial comparing the efficacy of α-blocker or 5α-reductase inhibitor withdrawal to continued combination therapy on the maintenance of lower urinary tract symptoms in men with benign prostatic hyperplasiaKwang Suk Lee, Jeong Woo Yoo, Dae Ho Kim, et al.
The Prostate|December 25, 2023
PrLZ regulates EMT and invasion in prostate cancer via the TGF-β1/p-smad2/miR-200 family/ZEB1 axisHongjun Xie, Jiaqi Chen, Zhenkun Ma, et al.
The Prostate|February 8, 2024
Estimating disparities of prostate cancer burden and its attributable risk factors for males across the BRICS-plus, 1990-2019: A comparable study of key nations with emerging economiesLi-Sha Luo, Jiao Huang, Hang-Hang Luan, et al.
The Prostate|February 5, 2024
Impact of presentation timing in metastatic hormone-sensitive prostate cancer: Characterization of patients and identification of prognostic factorsJuliana Arenas Hoyos, David Ruiz Londoño, Andres Gomez Hoyos, et al.
The Prostate|February 5, 2024
Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open-label, phase 2 trialAlbertas Ulys, Feliksas Jankevicus, Mindaugas Jievaltas, et al.
The Prostate|January 9, 2024
Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathwaysJason A White, Ernest T Kaninjing, Kayode A Adeniji, et al.
The Prostate|January 12, 2024
Metabolic analysis using HR-MAS in prostate tissue for prostate cancer diagnosisJorge Panach-Navarrete, Vannina González-Marrachelli, José Manuel Morales-Tatay, et al.
The Prostate|March 18, 2024
VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approachHendrik Heers, Oliver Chwilka, Johannes Huber, et al.
Pageof 592